Mannkind (MNKD) Total Debt Growth (1y) (2011 - 2026)
Mannkind (MNKD) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
5.94% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Mannkind |
1.13 Bn |
995.19 Mn |
82.66 Mn |
-0.55% |
| Date | Value |
|---|
| Mar 31, 2026 |
-0.55% |
| Dec 31, 2025 |
-0.50% |
| Sep 30, 2025 |
-19.49% |
| Jun 30, 2025 |
-0.29% |
| Dec 31, 2024 |
-0.16% |
| Sep 30, 2024 |
1,077.91% |
| Jun 30, 2024 |
1,077.94% |
| Dec 31, 2023 |
1,079.17% |
| Jun 30, 2021 |
140.05% |
| Jun 30, 2020 |
-97.49% |
| Jun 30, 2019 |
-26.54% |
| Mar 31, 2019 |
-28.02% |
| Dec 31, 2018 |
-37.02% |
| Sep 30, 2018 |
-37.25% |
| Jun 30, 2018 |
-19.65% |
| Mar 31, 2018 |
-4.46% |
| Dec 31, 2017 |
9.56% |
| Sep 30, 2017 |
14.28% |
| Jun 30, 2017 |
9.74% |
| Mar 31, 2017 |
-2.58% |
